As Seen On
Clinical Pipeline
We’re advancing a pipeline of small cell biologics with potential OTC impact — bridging lab breakthroughs with regulatory-ready therapies.
Scalable Innovation
Our R&D platform is designed for rapid development, testing, and production — ensuring therapies can move efficiently from bench to shelf.
Glaucoma is an eye condition often linked to elevated intraocular pressure (IOP), which can damage the optic nerve and lead to vision loss if not treated early.
MCI is defined as mild cognitive impairment that doesn’t interfere with daily activities, while Alzheimer’s is severe. It impacts daily functioning and is a progressive disease.
Infertility is defined as the inability to conceive after one year of unprotected intercourse.
We are a proud U.S. manufacturer. All of our manufacturing, research and development, and operations are conducted entirely within the United States.
